SORLA attenuates EphA4 signaling and amyloid β–induced neurodegeneration
Autor: | Thomas E. Willnow, Timothy Y. Huang, Eliezer Masliah, Yan Liu, Xiaoguang Li, Juan C. Piña-Crespo, Huaxi Xu, Yingjun Zhao, Bing Zhu, Elena B. Pasquale, Yu Sun, Lu-Lin Jiang |
---|---|
Rok vydání: | 2017 |
Předmět: |
0301 basic medicine
Genetically modified mouse Amyloid Growth Cones Long-Term Potentiation Immunology SORL1 Mice Transgenic Ligands Article Receptor tyrosine kinase Amyloid beta-Protein Precursor 03 medical and health sciences 0302 clinical medicine Protein Domains Alzheimer Disease medicine Animals Humans Immunology and Allergy Receptor LDL-Receptor Related Proteins Research Articles Mice Inbred BALB C biology Chemistry Neurodegeneration Receptor EphA4 Membrane Transport Proteins Long-term potentiation medicine.disease Cell biology HEK293 Cells 030104 developmental biology Receptors LDL Mutation Nerve Degeneration Synapses LDL receptor biology.protein Ephrins 030217 neurology & neurosurgery Protein Binding |
Zdroj: | The Journal of Experimental Medicine |
ISSN: | 1540-9538 0022-1007 |
DOI: | 10.1084/jem.20171413 |
Popis: | Huang et al. show that the Alzheimer’s disease (AD) risk factor SORLA inhibits amyloid β–induced synaptotoxicity and cognitive impairment through interacting with and subsequently inactivating EphA4. These findings provide a novel mechanism by which the SORLA loss-of-function mutation significantly increases AD risk. Sortilin-related receptor with LDLR class A repeats (SORLA, SORL1, or LR11) is a genetic risk factor associated with Alzheimer’s disease (AD). Although SORLA is known to regulate trafficking of the amyloid β (Aβ) precursor protein to decrease levels of proteotoxic Aβ oligomers, whether SORLA can counteract synaptic dysfunction induced by Aβ oligomers remains unclear. Here, we show that SORLA interacts with the EphA4 receptor tyrosine kinase and attenuates ephrinA1 ligand–induced EphA4 clustering and activation to limit downstream effects of EphA4 signaling in neurons. Consistent with these findings, SORLA transgenic mice, compared with WT mice, exhibit decreased EphA4 activation and redistribution to postsynaptic densities, with milder deficits in long-term potentiation and memory induced by Aβ oligomers. Importantly, we detected elevated levels of active EphA4 in human AD brains, where EphA4 activation is inversely correlated with SORLA/EphA4 association. These results demonstrate a novel role for SORLA as a physiological and pathological EphA4 modulator, which attenuates synaptotoxic EphA4 activation and cognitive impairment associated with Aβ-induced neurodegeneration in AD. |
Databáze: | OpenAIRE |
Externí odkaz: |